Mounjaro®
Starting from £179.99/mo
Start journey Learn moreWegovy's pre-filled pens are not designed to deliver a half dose. Each pen is factory-set to inject the full prescribed amount in a single press, and the licensed schedule (confirmed in the Wegovy Summary of Product Characteristics on the electronic Medicines Compendium (eMC)) does not include partial doses. If side effects are making a full dose difficult to tolerate, the right conversation is with your prescriber, not with the plunger mechanism. Semaglutide is a prescription-only medicine, and any change to how you take it should go through a clinician who can see your full picture.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The evidence starts with the device itself. Wegovy pens are pre-set injection systems: you attach a needle, press the button, and the pen delivers the complete dose in one automated stroke. There is no dial to turn back, no gradation marker to aim at, and no way to verify how much medicine was actually released if you try to stop mid-injection. The NHS semaglutide medicines page is explicit that doses should be taken as prescribed, the full amount, once a week, on a consistent day.
Even if the mechanics were straightforward, the remaining medicine in a used pen cannot safely be drawn into a syringe for a second injection later in the week. Once the needle has been attached and the pen activated, the sterility of the dose is no longer guaranteed. This is why the patient information leaflet advises disposing of the pen after each use, even if medicine appears to remain.
For readers who want a deeper look at how clicks, plunger travel and dose accuracy relate to one another, the detail on Wegovy half-dose clicks covers the mechanics specifically.
Most people asking about a Wegovy half dose are doing so because nausea, fatigue or digestive discomfort is making the current dose feel too much. That response is genuinely common, the STEP 1 trial, published in the New England Journal of Medicine, documented gastrointestinal side effects as the most frequent reason participants discontinued treatment. The licensed titration schedule was designed with exactly this problem in mind.
Starting at 0.25 mg (a dose that has no weight-loss effect by itself but gives your system time to adjust) and stepping up slowly every four weeks means the prescriber has several lower rungs available before reaching the 2.4 mg maintenance dose. If 1.7 mg is causing persistent nausea, a prescriber can decide to stay there longer rather than push upward, or to step back to 1.0 mg temporarily. Those moves are documented, clinically supported and reversible. If you are wondering whether taking half a dose of Wegovy is a safe workaround, the short answer is that improvising at home is none of those things.
You can get a sense of the full dose ladder on the Wegovy doses overview, which covers what each step is intended to achieve.
A quick practical check worth doing before your next injection: look up when you last changed your dose. If it was fewer than four weeks ago and side effects are still peaking, your body may simply not have had time to adjust, many people find the first ten to fourteen days after a step-up are the hardest, and symptoms then settle. Waiting and flagging the issue to your prescriber is often more productive than trying to engineer a smaller injection.
If side effects are severe or persistent rather than just uncomfortable, that conversation with a prescriber becomes urgent rather than optional. Dose pauses, extended time at a lower level, or in some cases a reassessment of whether Wegovy is the right treatment are all legitimate clinical options. If you have already looked into whether you can inject half a dose of Wegovy, it is worth knowing that none of those clinical options require you to modify a device that was not built to be modified.
Our clinical team at nume reviews every patient's progress before each repeat, that review is the moment to raise exactly this kind of concern. If you are already on treatment elsewhere and struggling, you can also read about how Wegovy works as a treatment to understand what adjustments are within the licensed framework.
For anyone still at the earliest stage and unsure whether semaglutide is right for them, understanding how the Wegovy pen handles dosing is a useful starting point before the free consultation at nume, where a GPhC-registered prescriber reviews every submission the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.